 |
114 Diseases |  |
151 Trials |
|
151 Trials |  |
5480 News |  |
| «12...156157158159160161162163164165166167168» |
- doxycycline / Generic mfg., azithromycin / Generic mfg.
New P4 trial: The interaction of antibiotics, gut flora and viruses in healthy volunteers. (EUDRACT) - Apr 8, 2014
P4, N=10, Ongoing, Sponsor: Department of Medicine, K
- |||| Vectibix (panitumumab) / Amgen
Trial completion, Metastases: STEPP: Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy (clinicaltrials.gov) - Mar 27, 2014
P2, N=95, Completed, Sponsor: Amgen
Active, not recruiting --> Completed
- linezolid oral / Generic mfg.
Clinical data: PRESTO:Osteo: Patients Response to Early Switch To Oral:Osteomyelitis Study (clinicaltrials.gov) - Mar 26, 2014
P0, N=456, Not yet recruiting, Sponsor: Julio Ramirez
- doxycycline / Generic mfg.
New P2 trial: A Phase II Study of Doxycycline in Relapsed NHL (clinicaltrials.gov) - Mar 11, 2014
P2, N=20, Not yet recruiting, Sponsor: University of Rochester
- vancomycin / Generic mfg., doxycycline / Generic mfg.
Trial completion: Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA) (clinicaltrials.gov) - Mar 10, 2014
P=N/A, N=178, Completed, Sponsor: New York University School of Medicine
Active, not recruiting --> Completed Active, not recruiting --> Completed
- doxycycline / Generic mfg., irbesartan / Generic mfg.
Enrollment open, MRI: The Oxford Marfan Trial (clinicaltrials.gov) - Mar 5, 2014
P2, N=56, Recruiting, Sponsor: University of Oxford
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | azithromycin / Generic mfg.
Trial completion: Azithromycin/Bicillin Syphilis (clinicaltrials.gov) - Feb 22, 2014
P3, N=593, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | doxycycline / Generic mfg.
Trial completion: Adjunctive Treatment With Doxycycline to Enhance the Durability of Endovascular Aortic Aneurysm Repair (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=75, Completed, Sponsor: Barnes-Jewish Hospital
Active, not recruiting --> Completed Recruiting --> Completed
- | ceftriaxone / Generic mfg., doxycycline / Generic mfg.
Trial completion: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease (clinicaltrials.gov) - Feb 19, 2014
P3, N=66, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed No longer recruiting --> Completed
- phenoxymethylpenicillin / Generic mfg., doxycycline / Generic mfg., amoxicillin / Generic mfg.
Enrollment closed: NorTick_EM: Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice (clinicaltrials.gov) - Feb 12, 2014
P4, N=225, Active, not recruiting, Sponsor: Morten Lindbaek
No longer recruiting --> Completed Recruiting --> Active, not recruiting
- | minocycline / Generic mfg.
New P1/2 trial: NAEDRAP: The Effect of Nebulization of Alkaline Solution on Treating XDRAB Pneumonia With C/S Plus Minocycline (clinicaltrials.gov) - Feb 9, 2014
P1/2, N=90, Not yet recruiting, Sponsor: Xijing Hospital
- doxycycline / Generic mfg.
Trial completion, Adverse events, Adherence: Side Effects and Adherence Associated With Doxycycline Use Following Medical Abortion (clinicaltrials.gov) - Jan 29, 2014
P=N/A, N=582, Completed, Sponsor: Gynuity Health Projects
Recruiting --> Active, not recruiting Recruiting --> Completed
- Ciprodex (ciprofloxacin 0.3% and dexamethasone 0.1%) / Novartis
Enrollment open: Manipulating the Microbiome in IBD by Antibiotics and FMT (clinicaltrials.gov) - Jan 14, 2014
P4, N=20, Recruiting, Sponsor: Shaare Zedek Medical Center
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| gentamicin sulfate / Generic mfg.
New P1/2 trial: Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers (clinicaltrials.gov) - Jan 13, 2014
P1/2, N=86, Recruiting, Sponsor: Royer Biomedical, Inc.
- |||| gentamicin sulfate / Generic mfg.
Enrollment open: Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers (clinicaltrials.gov) - Jan 12, 2014
P1/2, N=86, Recruiting, Sponsor: Royer Biomedical, Inc.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Ciprodex (ciprofloxacin 0.3% and dexamethasone 0.1%) / Novartis
New P4 trial: Manipulating the Microbiome in IBD by Antibiotics and FMT (clinicaltrials.gov) - Jan 8, 2014
P4, N=20, Recruiting, Sponsor: Shaare Zedek Medical Center
- doxycycline / Generic mfg., ursodeoxycholic acid / Generic mfg.
New P2 trial: Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis (clinicaltrials.gov) - Dec 18, 2013
P2, N=30, Recruiting, Sponsor: Umeå University
- | prednisone / Generic mfg., doxycycline / Generic mfg.
Enrollment change: Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy (clinicaltrials.gov) - Dec 6, 2013
P2/3, N=146, Recruiting, Sponsor: Sun Yat-sen University
Not yet recruiting --> Recruiting N=116 --> 146
- | albendazole / Generic mfg., doxycycline / Generic mfg.
New P4 trial: Alternate Chemotherapy Regimens for the Clearance of W.Bancrofti Infection (clinicaltrials.gov) - Dec 5, 2013
P4, N=146, Completed, Sponsor: Indian Council of Medical Research
- ||||||| doxycycline / Generic mfg., adapalene/benzoyl peroxide / Generic mfg., isotretinoin / Generic mfg.
Trial completion: Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne (clinicaltrials.gov) - Nov 21, 2013
P3, N=266, Completed, Sponsor: Galderma
N=116 --> 146 Active, not recruiting --> Completed
- doxycycline / Generic mfg.
Trial completion: Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy (clinicaltrials.gov) - Nov 20, 2013
P1/2, N=14, Completed, Sponsor: Sun Yat-sen University
Active, not recruiting --> Completed Recruiting --> Completed
- Erbitux (cetuximab) / Eli Lilly, EMD Serono
Clinical: Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients (clinicaltrials.gov) - Nov 7, 2013
P1, N=100, Recruiting, Sponsor: James Graham Brown Cancer Center
Recruiting --> Completed Not yet recruiting --> Recruiting
- tetracycline / Generic mfg.
Trial completion: Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms (clinicaltrials.gov) - Oct 7, 2013
P1, N=26, Completed, Sponsor: University of California, San Francisco
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | doxycycline / Generic mfg., irbesartan / Generic mfg.
New P2 trial, MRI: The Oxford Marfan Trial (clinicaltrials.gov) - Sep 22, 2013
P2, N=56, Recruiting, Sponsor: University of Oxford
- doxycycline / Generic mfg.
New P2 trial: DOXY-HF: Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy (clinicaltrials.gov) - Sep 3, 2013
P2, N=24, Recruiting, Sponsor: Virginia Commonwealth University
- ||| Erbitux (cetuximab) / Eli Lilly, EMD Serono
New P3 trial: Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT (clinicaltrials.gov) - Aug 27, 2013
P3, N=40, Recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
- | Erbitux (cetuximab) / Eli Lilly, EMD Serono
Enrollment open: Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT (clinicaltrials.gov) - Aug 27, 2013
P3, N=40, Recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||| doxycycline / Generic mfg.
Trial completion: Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo (clinicaltrials.gov) - Aug 18, 2013
P4, N=170, Completed, Sponsor: Galderma Laboratories, L.P.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- doxycycline / Generic mfg.
Trial initiation date: Low Dose Doxycycline in the Treatment of Corneal Burn (clinicaltrials.gov) - Aug 6, 2013
P2/3, N=40, Not yet recruiting, Sponsor: Sun Yat-sen University
Active, not recruiting --> Completed Initiation date: Jun 2013 --> Sep 2013
- doxycycline / Generic mfg.
New P2 trial: Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease (clinicaltrials.gov) - Aug 5, 2013
P2, N=50, Not yet recruiting, Sponsor: Hawaii Pacific Health
- ceftriaxone / Generic mfg.
Enrollment closed: PLEASE: Persistent Lyme Empiric Antibiotic Study Europe (clinicaltrials.gov) - Jul 11, 2013
P4, N=270, Active, not recruiting, Sponsor: Radboud University
Initiation date: Jun 2013 --> Sep 2013 Recruiting --> Active, not recruiting
- doxycycline / Generic mfg.
Trial completion: Trial of Doxycycline to Reduce Sputum MMP-9 Activity in Adult Cystic Fibrosis (CF) Patients (clinicaltrials.gov) - Jul 10, 2013
P=N/A, N=40, Completed, Sponsor: University of Alabama at Birmingham
Recruiting --> Active, not recruiting Recruiting --> Completed
- doxycycline / Generic mfg., azithromycin / Generic mfg.
Trial completion: Oral Azithromycin Versus Doxycycline in Posterior Blepharitis (clinicaltrials.gov) - Jul 7, 2013
P2, N=100, Completed, Sponsor: Tehran University of Medical Sciences
Recruiting --> Completed Recruiting --> Completed
- | doxycycline / Generic mfg.
Trial completion: Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea (clinicaltrials.gov) - Jun 30, 2013
P4, N=24, Completed, Sponsor: Galderma Laboratories, L.P.
Recruiting --> Completed Recruiting --> Completed
- doxycycline / Generic mfg.
New P2/3 trial: Low Dose Doxycycline in the Treatment of Corneal Burn (clinicaltrials.gov) - Jun 24, 2013
P2/3, N=40, Not yet recruiting, Sponsor: Sun Yat-sen University
- | doxycycline / Generic mfg.
New P4 trial: Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective Study (clinicaltrials.gov) - Jun 16, 2013
P4, N=88, Recruiting, Sponsor: University Hospital Inselspital, Berne
- Erbitux (cetuximab) / Eli Lilly, EMD Serono
Clinical: Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients (clinicaltrials.gov) - Jun 9, 2013
P1, N=100, Recruiting, Sponsor: James Graham Brown Cancer Center
- doxycycline / Generic mfg.
Trial withdrawal: Study of NanoDOX Hydrogel vs Placebo for Dehisced Surgical Wounds (clinicaltrials.gov) - Jun 5, 2013
P=N/A, N=0, Withdrawn, Sponsor: Nanotherapeutics, Inc.
Recruiting --> Completed Not yet recruiting --> Withdrawn
- doxycycline / Generic mfg.
Enrollment change: Study of NanoDOX Hydrogel vs Placebo for Dehisced Surgical Wounds (clinicaltrials.gov) - Jun 5, 2013
P=N/A, N=0, Withdrawn, Sponsor: Nanotherapeutics, Inc.
Not yet recruiting --> Withdrawn N=10 --> 0
- | doxycycline / Generic mfg.
New P4 trial: Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea (clinicaltrials.gov) - Jun 5, 2013
P4, N=24, Completed, Sponsor: Galderma Laboratories, L.P.
- | Erbitux (cetuximab) / Eli Lilly, EMD Serono, Vectibix (panitumumab) / Amgen, Takeda
New P2 trial, Metastases: Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab (clinicaltrials.gov) - Jun 2, 2013
P2, N=80, Recruiting, Sponsor: Academic and Community Cancer Research United
- | prednisone / Generic mfg., doxycycline / Generic mfg.
Enrollment open: Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy (clinicaltrials.gov) - Jun 2, 2013
P2/3, N=146, Recruiting, Sponsor: Sun Yat-sen University
N=10 --> 0 Active, not recruiting --> Recruiting
- doxycycline / Generic mfg.
Trial termination: Doxycycline Versus Standard Care to Prevent Seroma Formation (clinicaltrials.gov) - May 27, 2013
P=N/A, N=70, Terminated, Sponsor: North Shore Long Island Jewish Health System
Active, not recruiting --> Recruiting Recruiting --> Terminated; The recruitment process was slower than expected.
- doxycycline / Generic mfg.
Enrollment change: Doxycycline Versus Standard Care to Prevent Seroma Formation (clinicaltrials.gov) - May 27, 2013
P=N/A, N=70, Terminated, Sponsor: North Shore Long Island Jewish Health System
Recruiting --> Terminated; The recruitment process was slower than expected. N=303 --> 70
- Vectibix (panitumumab) / Amgen
Trial termination, Metastases: SKIP - A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity Treatment (clinicaltrials.gov) - May 16, 2013
P2, N=11, Terminated, Sponsor: Gesellschaft fur Medizinische Innovation
Prev. differentiation of RAS-wild-type and mutated RAS are not in accordance with the scientific rank anymore.
- Vectibix (panitumumab) / Amgen
Enrollment change, Metastases: SKIP - A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity Treatment (clinicaltrials.gov) - May 16, 2013
P2, N=11, Terminated, Sponsor: Gesellschaft fur Medizinische Innovation
differentiation of RAS-wild-type and mutated RAS are not in accordance with the scientific rank anymore. N=84 --> 11
- ||| doxycycline / Generic mfg.
Enrollment closed: A Clinical Trial of YH14642 in Patients With Chronic Periodontal Disease (clinicaltrials.gov) - May 12, 2013
P2, N=162, Active, not recruiting, Sponsor: Yuhan Corporation
N=84 --> 11 Recruiting --> Active, not recruiting
- | doxycycline / Generic mfg., azithromycin / Generic mfg.
New P4 trial: Duration of Antibiotic Therapy as Part of Maximal Medical Therapy for Chronic Rhinosinusitis (clinicaltrials.gov) - Apr 3, 2013
P4, N=100, Recruiting, Sponsor: University of North Carolina, Chapel Hill
- doxycycline / Generic mfg.
New P2 trial: IELSG39: Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment (clinicaltrials.gov) - Mar 27, 2013
P2, N=34, Recruiting, Sponsor: International Extranodal Lymphoma Study Group (IELSG)
- | New P4 trial, HEOR, Surgery, Cost effectiveness: Does a longer course of antibiotics reduce the incidence of wound infections after amputation surgery? (EUDRACT) - Mar 13, 2013
P4, N=164, Ongoing, Sponsor: Hull and East Yorkshire Hospital Trust